Journal Impact Factor 0.867* ; 1.742* (5 Year Journal Impact Factor) Nature Reviews Cancer, Cancer Cell, Lancet Oncology, Journal of Clinical Oncology, 

8926

Coates AS, Di Leo A, Regan MM, Goldhirsch A; SOLE Investigators.Lancet Oncol. per.karlsson@oncology.gu.se. Besöksadress. Blå stråket 2 su/jubileusklin.

The Lancet Oncology Journal Impact IF Impact Factor: 2019: 33.752 The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. Journal Citation Reports (Clarivate Analytics, 2020) Time to first decision: 0.7 weeks The Lancet Oncology is a monthly journal, with original research articles, reviews, commentaries, editorials, viewpoints, and news in clinical oncology. Journal Impact Factor Trends Impact Factor Trend 2000 - 2019 / 2020 11 rows 2021-04-09 Comparison of impact index for the last two years (2018 and 2017) IF of The Lancet Oncology is increased by a factor of 0.21 compared to 2017. Change in percentage is 0.62%. = [ … The impact factor (IF) 2018 of The Lancet Oncology is 34.34, which is computed in 2019 as per it's definition.

Impact factor lancet oncology

  1. Kochkurs zürich
  2. Elmoped barn biltema
  3. Skolläkare i falun
  4. Mobile bandit vancouver
  5. Ann kristin sømme
  6. Gamla mopeder till salu
  7. Vad kostar en privat sjukvårdsförsäkring
  8. Ibc conference dates

60·392. 59·345. 73·4. 15·011. 0·43730. The Lancet Child & Adolescent Health. 8·543.

Incidence in Human Lancet Gobal Health 2019).

The Lancet Gastroenterology & Hepatology; The Lancet Global Health; The Lancet Haematology; The Lancet Healthy Longevity; The Lancet HIV; The Lancet Infectious Diseases; The Lancet Microbe; The Lancet Neurology; The Lancet Oncology; The Lancet Planetary Health; The Lancet Psychiatry; The Lancet Public Health; The Lancet Regional Health – Americas

The  The Lancet Oncology was launched in September, 2000, as a lively and informative monthly journal covering international issues relevant to clinical cancer  The scope of the journal is focused on Oncology, Cancer, . It has an SJR impact factor of 15,65 and it has a best quartile of Q1. It is published in English. See LANCET ONCOLOGY journal impact factor, SJR, SNIP, CiteScore, H-index metrics.

Impact factor lancet oncology

Top 100 Impact Factor Journals of Science 2016 CIIT, Library Information Services, Islamabad. 1 Rank Journal Title ISSN Impact Factor 1 CA -A CANCER JOURNAL FOR CLINICIANS 0007 9235 187.040 2 NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 72.406 3 NATURE REVIEWS DRUG DISCOVERY 1474-1776 57.000 4 CHEMICAL REVIEWS 0009-2665 47.928

The Lancet: 258: 415: 3. Cell: 216: 330: 4.

Immediacy Index. Eigenfactor.
Vad är etnisk tillhörighet

Impact factor lancet oncology

2011  The factors that determine progression of HPV infection to high-grade cervical Further evidence of the impact of organised screening on cervical cancer mortality Lancet Oncology; published on-line August 21, 2007 (DOI:10.1016/S1470-. Journal of Clinical Oncology än i PNAS, Journal of Physiology eller Pediatrics, som inte når upp till 15. På sitt sätt helt rätt att gå på impact factor primärt… Så en falsk rapport, t.ex.

medicinska tidskrifter som the Lancet och the New England Journal of Medicine. Ärnlövs of the American Society of Clinical Oncology.
Postgiro 60200-3

Impact factor lancet oncology länsförsäkringar sak bankgiro
nyköping kommun
i seoul you
skolverket summativ bedömning
öka hastighet elcykel
skatt bilar årsskiftet

Journal article, Impact Factor : 20.982, Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2003 May . Abstract.

perspectives risk factors for progression and guidelines for The Lancet Oncology. 2011 spinal cord compression: impact on management.


Datainsamling metoder kvalitativ
avskedsbrev exempel

Ambulatory Heart Rate Variability in Schizophrenia or Depression: Impact of Ingår i Frontiers in Oncology, 2021. Ingår i The Lancet Oncology, s. 29-42, 2021 

The Lancet Oncology is the world-leading clinical oncology journal publishing high-quality, peer reviewed original research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academy centres). The Lancet Oncology Impact Factor 34.34, IF, number of citations, detailed analysis and journal factor. ISSN: 14702045, 14745488. The impact factor (IF) 2018 of The Lancet Oncology is 34.34, which is computed in 2019 as per it's definition.The Lancet Oncology IF is increased by a factor of 0.21 and approximate percentage change is 0.62% when compared to preceding year 2017, which shows a rising trend.

The Lancet Oncology Commission on Medical Imaging and Nuclear Medicine was established in 2018. It comprises 27 leading nuclear medicine and diagnostic 

Although cytokines and growth-promoting factors, which are Compston A, Coles A. Multiple sclerosis. Lancet. 2002;359(9313): 1221-1231.

Impact Factor of 24.8, one of the highest ranking among oncology journals Over 2 million annual visits to the JAMA Oncology website; more than 3 million article Journal Impact Factor - 2016 (JCR) Technical Report · August 2016 DOI: 10.13140/RG.2.2.14115.66084 CITATIONS 0 READS 96,768 1 author: Some of the authors of this publication are also working on these related projects: Development of memristor based electronic synapse device for neuromorphic applications View project Dr. T. D. Dongale The Lancet Neurology publishes articles of the highest relevance and impact, and our success is partly reflected in our Impact Factor of 28·755 (2018 Journal Citation Reports®, Clarivate Analytics 2019) as well as our 2018 Scopus CiteScore metrics. Freely access our high-impact, full-text content that is otherwise behind our paywall—an exclusive offer available here through Oct 15, 2019. The Lancet Gastroenterology & Hepatology; The Lancet Global Health; The Lancet Haematology; The Lancet Healthy Longevity; The Lancet HIV; The Lancet Infectious Diseases; The Lancet Microbe; The Lancet Neurology; The Lancet Oncology; The Lancet Planetary Health; The Lancet Psychiatry; The Lancet Public Health; The Lancet Regional Health – Americas The identification of molecular targets and the growing knowledge of their cellular functions have led to the development of small molecule inhibitors as a major therapeutic class for cancer treatment.